Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ; International Workshop on Chronic Lymphocytic Leukemia..

Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23. Erratum in: Blood. 2008 Dec 15;112(13):5259.

2.

Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.

Patel A, Kang SH, Lennon PA, Li YF, Rao PN, Abruzzo L, Shaw C, Chinault AC, Cheung SW.

Am J Hematol. 2008 Jul;83(7):540-6.

3.

High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia.

Tyybakinoja A, Vilpo J, Knuutila S.

Cytogenet Genome Res. 2007;118(1):8-12.

PMID:
17901694
4.

Structural variation in the human genome: the impact of copy number variants on clinical diagnosis.

Rodriguez-Revenga L, Mila M, Rosenberg C, Lamb A, Lee C.

Genet Med. 2007 Sep;9(9):600-6. Review.

PMID:
17873648
5.

Challenges in array comparative genomic hybridization for the analysis of cancer samples.

Nowak NJ, Miecznikowski J, Moore SR, Gaile D, Bobadilla D, Smith DD, Kernstine K, Forman SJ, Mhawech-Fauceglia P, Reid M, Stoler D, Loree T, Rigual N, Sullivan M, Weiss LM, Hicks D, Slovak ML.

Genet Med. 2007 Sep;9(9):585-95.

PMID:
17873646
6.

Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.

Santana-Davila R, Holtan SG, Dewald GW, Ketterling RP, Knudson RA, Hanson CA, Steensma DP, Tefferi A.

Leuk Res. 2008 Mar;32(3):407-11. Epub 2007 Aug 20.

PMID:
17707907
7.

Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia.

Grever MR, Lucas DM, Johnson AJ, Byrd JC.

Best Pract Res Clin Haematol. 2007 Sep;20(3):545-56.

PMID:
17707839
8.

Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.

Zenz T, Döhner H, Stilgenbauer S.

Best Pract Res Clin Haematol. 2007 Sep;20(3):439-53. Review.

PMID:
17707832
9.

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.

Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D, Kröber A, Kienle D, Lichter P, Döhner H.

Haematologica. 2007 Sep;92(9):1242-5. Epub 2007 Aug 1.

10.

Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia.

Sellmann L, Gesk S, Walter C, Ritgen M, Harder L, Martín-Subero JI, Schroers R, Siemer D, Nückel H, Dyer MJ, Dührsen U, Siebert R, Dürig J, Küppers R.

Br J Haematol. 2007 Jul;138(2):217-20.

PMID:
17593029
11.

Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events.

Wlodarska I, Matthews C, Veyt E, Pospisilova H, Catherwood MA, Poulsen TS, Vanhentenrijk V, Ibbotson R, Vandenberghe P, Morris TC, Alexander HD.

J Mol Diagn. 2007 Feb;9(1):47-54.

12.

Array-based comparative genomic hybridization and copy number variation in cancer research.

Cho EK, Tchinda J, Freeman JL, Chung YJ, Cai WW, Lee C.

Cytogenet Genome Res. 2006;115(3-4):262-72. Review.

PMID:
17124409
13.

Application of array-based comparative genomic hybridization to clinical diagnostics.

Bejjani BA, Shaffer LG.

J Mol Diagn. 2006 Nov;8(5):528-33. Review.

14.

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, Fisch P, Timmer J, Veelken H.

Blood. 2007 Feb 1;109(3):1202-10. Epub 2006 Oct 19.

15.

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW.

J Clin Oncol. 2006 Oct 1;24(28):4634-41.

PMID:
17008705
16.

Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia.

Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW.

Cancer Genet Cytogenet. 2006 Jun;167(2):177-81.

PMID:
16737921
17.
18.

Structural variation in the human genome.

Feuk L, Carson AR, Scherer SW.

Nat Rev Genet. 2006 Feb;7(2):85-97. Review.

PMID:
16418744
19.

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.

Kröber A, Bloehdorn J, Hafner S, Bühler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2006 Feb 20;24(6):969-75. Epub 2006 Jan 17.

PMID:
16418492
20.

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner CM.

Blood. 2006 Jan 15;107(2):742-51. Epub 2005 Sep 22.

Supplemental Content

Support Center